Home Page

csid diet

501c-3 Pending

Celebrating 21 Years

Articles
What is CSID?
Diagnosing CSID

Medical Resources
Symptoms
Typical Emergencies
Hospital Visits
Sucrose Free Drugs
Doctors & Dieticians

Medical Alert Tags
Support
Contact Us
Nutrition
Food Composition
Charts
Recipes
Induction Diet
Cracker Test
MedDiary
Holidays
Res ources & Supplies
Treatments
Sucraid™
Enzymes
Vitamins
Vaccinations
Research
Genetic Information
Colon Cancer
CSID Research
Reading Room
Journal Articles
Slide Decks
FAQ
School Forms
Children’s Corner
Family Experiences

News

Notification from FDA Regarding Sucraid

The CSID Society received notification from the Food and Drug Administration regarding the drug Sucraid. Please refer directly to the FDA website for accurate and current information regarding the Sucraid drug shortage. The following is the information provided by the FDA:

In the posting there is a link to the Physician and Patient Informed Consent Forms, and QOL’s Questionnaire, and a link to related information for the public to reserve supply for serious cases. The forms state:

“As a temporary measure, since Sucraid is in shortage, the FDA has allowed the release of Sucraid lot number A1147. This lot of Sucraid was manufactured at an unapproved facility under conditions that did not meet FDA’s standards for pharmaceuticals.”

Leave a Reply

Your email address will not be published. Required fields are marked *